2seventy bio, China’s JW Therapeutics sign pact for cancer therapy
2seventy bio, Inc., an immuno-oncology cell therapy company, and China’s JW Therapeutics, announced a pact to establish a platform to explore T cell-based.
2seventy bio, Inc., an immuno-oncology cell therapy company, and China’s JW Therapeutics, announced a pact to establish a platform to explore T cell-based.
China, the US, and India are expected to have the highest economic cost of overweight and obesity, a study by the World Obesity.